United States, April 3 -- GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True Definition DL, the latest addition to its growing portfolio of deep learning image reconstruction solutions for computed tomography (CT). Designed to deliver crisp, high-resolution images with exceptional sharpness, True Definition DL builds on the company's established TrueFidelity DL and True Enhance DL technologies - helping support fast scans and broader coverage across pulmonary, musculoskeletal, and inner ear imaging. As chronic diseases continue to rise worldwide, the demand for fast, precise imaging is accelerating. The cancer burden alone is projected to increase by over 75 percent by 2050, while cardiovas...